Previous Article | Next Article 
Molecular and Cellular Biology, April 2002, p. 2575-2585, Vol. 22, No. 8
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.8.2575-2585.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Autoinhibitory Regulation of p73 by
Np73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the
Np73 Promoter
Takahito Nakagawa,1,2 Masato Takahashi,1,2 Toshinori Ozaki,1 Ken-ichi Watanabe,1,2 Satoru Todo,2 Hiroyuki Mizuguchi,3 Takao Hayakawa,3 and Akira Nakagawara1*
Division of Biochemistry, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba 260-8717,1
Department of General Surgery, Hokkaido University School of Medicine, Kita-ku, Sapporo 060-8638,2
Division of Biological Chemistry and Biologicals, National Institute of Health Science, Setagaya-ku, Tokyo 158-8501, Japan3
Received 13 August 2001/
Returned for modification 9 October 2001/
Accepted 7 January 2002
p73 is a p53-related tumor suppressor but is also induced by oncogene products such as E2F-1, raising a question as to whether p73 is a tumor suppressor gene or oncogene. Unlike p53, p73 has several variants, including
Np73, which lacks the NH2-terminal transactivation domain. Although, in developing neurons,
Np73 is expressed abundantly and seems to inhibit the proapoptotic function of p53, the role of p73 and
Np73 and their regulatory mechanism in cell growth and differentiation are poorly understood. Here we report that p73, but not p53, directly activates the transcription of endogenous
Np73 by binding to the p73-specific target element located at positions -76 to -57 within the
Np73 promoter region. The activation of
Np73 promoter by p63 was marginal.
Np73 was associated with p73
, p73ß, and p53, as demonstrated by immunoprecipitation assays, and inhibited their transactivation activities when we used reporters of Mdm2, Bax, or
Np73 itself in SAOS-2 cells. Furthermore, induction or overexpression of
Np73 promoted cell survival by competing with p53 and p73 itself. Thus, our results suggest that the negative feedback regulation of p73 by its target
Np73 is a novel autoregulatory system for modulating cell survival and death.
* Corresponding author. Mailing address: Division of Biochemistry, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuoh-ku, Chiba 260-8717, Japan. Phone: 81-43-264-5431. Fax: 81-43-265-4459. E-mail: akiranak{at}chiba-ccri.chuo.chiba.jp.
Molecular and Cellular Biology, April 2002, p. 2575-2585, Vol. 22, No. 8
0022-538X/02/$04.00+0 DOI: 10.1128/MCB.22.8.2575-2585.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Horvilleur, E., Bauer, M., Goldschneider, D., Mergui, X., de La Motte, A., Benard, J., Douc-Rasy, S., Cappellen, D.
(2008). p73{alpha} isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells. Nucleic Acids Res
36: 4222-4232
[Abstract]
[Full Text]
-
Furuya, K., Ozaki, T., Hanamoto, T., Hosoda, M., Hayashi, S., Barker, P. A., Takano, K., Matsumoto, M., Nakagawara, A.
(2007). Stabilization of p73 by Nuclear I{kappa}B Kinase-{alpha} Mediates Cisplatin-induced Apoptosis. J. Biol. Chem.
282: 18365-18378
[Abstract]
[Full Text]
-
Lokshin, M., Li, Y., Gaiddon, C., Prives, C.
(2007). p53 and p73 display common and distinct requirements for sequence specific binding to DNA. Nucleic Acids Res
35: 340-352
[Abstract]
[Full Text]
-
Watson, I. R., Blanch, A., Lin, D. C. C., Ohh, M., Irwin, M. S.
(2006). Mdm2-mediated NEDD8 Modification of TAp73 Regulates Its Transactivation Function. J. Biol. Chem.
281: 34096-34103
[Abstract]
[Full Text]
-
Li, T. W.-H., Ting, J.-H. T., Yokoyama, N. N., Bernstein, A., van de Wetering, M., Waterman, M. L.
(2006). Wnt Activation and Alternative Promoter Repression of LEF1 in Colon Cancer.. Mol. Cell. Biol.
26: 5284-5299
[Abstract]
[Full Text]
-
Dominguez, G., Garcia, J. M., Pena, C., Silva, J., Garcia, V., Martinez, L., Maximiano, C., Gomez, M. E., Rivera, J. A., Garcia-Andrade, C., Bonilla, F.
(2006). {Delta}TAp73 Upregulation Correlates With Poor Prognosis in Human Tumors: Putative In Vivo Network Involving p73 Isoforms, p53, and E2F-1. JCO
24: 805-815
[Abstract]
[Full Text]
-
Osada, M., Park, H. L., Nagakawa, Y., Yamashita, K., Fomenkov, A., Kim, M. S., Wu, G., Nomoto, S., Trink, B., Sidransky, D.
(2005). Differential Recognition of Response Elements Determines Target Gene Specificity for p53 and p63. Mol. Cell. Biol.
25: 6077-6089
[Abstract]
[Full Text]
-
Tang, V., Dhirapong, A., Yabes, A. P., Weiss, R. H.
(2005). TNF-{alpha}-mediated apoptosis in vascular smooth muscle cells requires p73. Am. J. Physiol. Cell Physiol.
289: C199-C206
[Abstract]
[Full Text]
-
Saifudeen, Z., Diavolitsis, V., Stefkova, J., Dipp, S., Fan, H., El-Dahr, S. S.
(2005). Spatiotemporal Switch from {Delta}Np73 to TAp73 Isoforms during Nephrogenesis: IMPACT ON DIFFERENTIATION GENE EXPRESSION. J. Biol. Chem.
280: 23094-23102
[Abstract]
[Full Text]
-
Hanamoto, T., Ozaki, T., Furuya, K., Hosoda, M., Hayashi, S., Nakanishi, M., Yamamoto, H., Kikuchi, H., Todo, S., Nakagawara, A.
(2005). Identification of Protein Kinase A Catalytic Subunit {beta} as a Novel Binding Partner of p73 and Regulation of p73 Function. J. Biol. Chem.
280: 16665-16675
[Abstract]
[Full Text]
-
Goldschneider, D., Million, K., Meiller, A., Haddada, H., Puisieux, A., Benard, J., May, E., Douc-Rasy, S.
(2005). The neurogene BTG2TIS21/PC3 is transactivated by {Delta}Np73{alpha} via p53 specifically in neuroblastoma cells. J. Cell Sci.
118: 1245-1253
[Abstract]
[Full Text]
-
Uramoto, H., Wetterskog, D., Hackzell, A., Matsumoto, Y., Funa, K.
(2004). p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF {beta}-receptor. J. Cell Sci.
117: 5323-5331
[Abstract]
[Full Text]
-
Tomkova, K., Belkhiri, A., El-Rifai, W., Zaika, A. I.
(2004). p73 Isoforms Can Induce T-Cell Factor-Dependent Transcription in Gastrointestinal Cells. Cancer Res.
64: 6390-6393
[Abstract]
[Full Text]
-
Hobom, U., Dobbelstein, M.
(2004). E1B-55-Kilodalton Protein Is Not Required To Block p53-Induced Transcription during Adenovirus Infection. J. Virol.
78: 7685-7697
[Abstract]
[Full Text]
-
Moll, U. M., Slade, N.
(2004). p63 and p73: Roles in Development and Tumor Formation. Mol Cancer Res
2: 371-386
[Abstract]
[Full Text]
-
Ando, K., Ozaki, T., Yamamoto, H., Furuya, K., Hosoda, M., Hayashi, S., Fukuzawa, M., Nakagawara, A.
(2004). Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation. J. Biol. Chem.
279: 25549-25561
[Abstract]
[Full Text]
-
Kuiper, R. P., Schepens, M., Thijssen, J., Schoenmakers, E. F. P. M., van Kessel, A. G.
(2004). Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains. Nucleic Acids Res
32: 2315-2322
[Abstract]
[Full Text]
-
Chan, W. M., Siu, W. Y., Lau, A., Poon, R. Y. C.
(2004). How Many Mutant p53 Molecules Are Needed To Inactivate a Tetramer?. Mol. Cell. Biol.
24: 3536-3551
[Abstract]
[Full Text]
-
Concin, N., Becker, K., Slade, N., Erster, S., Mueller-Holzner, E., Ulmer, H., Daxenbichler, G., Zeimet, A., Zeillinger, R., Marth, C., Moll, U. M.
(2004). Transdominant {Delta}TAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo. Cancer Res.
64: 2449-2460
[Abstract]
[Full Text]
-
Melino, G., Bernassola, F., Ranalli, M., Yee, K., Zong, W. X., Corazzari, M., Knight, R. A., Green, D. R., Thompson, C., Vousden, K. H.
(2004). p73 Induces Apoptosis via PUMA Transactivation and Bax Mitochondrial Translocation. J. Biol. Chem.
279: 8076-8083
[Abstract]
[Full Text]
-
Liu, G., Nozell, S., Xiao, H., Chen, X.
(2004). {Delta}Np73{beta} Is Active in Transactivation and Growth Suppression. Mol. Cell. Biol.
24: 487-501
[Abstract]
[Full Text]
-
Goldschneider, D., Blanc, E., Raguenez, G., Barrois, M., Legrand, A., Le Roux, G., Haddada, H., Benard, J., Douc-Rasy, S.
(2004). Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line. J. Cell Sci.
117: 293-301
[Abstract]
[Full Text]
-
Stiewe, T., Tuve, S., Peter, M., Tannapfel, A., Elmaagacli, A. H., Putzer, B. M.
(2004). Quantitative TP73 Transcript Analysis in Hepatocellular Carcinomas. Clin. Cancer Res.
10: 626-633
[Abstract]
[Full Text]
-
Onel, K., Cordon-Cardo, C.
(2004). MDM2 and Prognosis. Mol Cancer Res
2: 1-8
[Abstract]
[Full Text]
-
Petrenko, O., Zaika, A., Moll, U. M.
(2003). {Delta}Np73 Facilitates Cell Immortalization and Cooperates with Oncogenic Ras in Cellular Transformation In Vivo. Mol. Cell. Biol.
23: 5540-5555
[Abstract]
[Full Text]
-
Stiewe, T., Stanelle, J., Theseling, C. C., Pollmeier, B., Beitzinger, M., Putzer, B. M.
(2003). Inactivation of Retinoblastoma (RB) Tumor Suppressor by Oncogenic Isoforms of the p53 Family Member p73. J. Biol. Chem.
278: 14230-14236
[Abstract]
[Full Text]
-
Freebern, W. J., Smith, J. L., Chaudhry, S. S., Haggerty, C. M., Gardner, K.
(2003). Novel Cell-specific and Dominant Negative Anti-apoptotic Roles of p73 in Transformed Leukemia Cells. J. Biol. Chem.
278: 2249-2255
[Abstract]
[Full Text]
-
Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., Chalas, E., Moll, U. M.
(2002). {Delta}Np73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors. J. Exp. Med.
196: 765-780
[Abstract]
[Full Text]
Copyright © 2002 by the American Society for Microbiology. All rights reserved.